Movement Disorders

The NeurologyLive movement disorders clinical focus page is a source for all the latest news regarding the clinical care of patients with Parkinson disease, essential tremor, Huntington disease, dystonia, ataxia, and more. This page features podcasts, videos, and news about FDA actions, study and clinical trial findings, clinical guideline updates, and interviews with experts in the clinical care of movement disorders.

Poor Extraocular Movements Linked to Decreased REM Sleep in Huntington Disease

November 18, 2021

Article

Patients with REM sleep percentage less than 15% were associated with poorer horizontal optokinetic nystagmus grades and more severe illness.

Side Effects of Apomorphine Usage in Parkinson’s Disease

November 16, 2021

Video

A panel of experts debate the disadvantages and side effects of apomorphine therapies for Parkinson’s disease.

Apomorphine Subcutaneous Injections for Parkinson’s Disease

November 16, 2021

Video

A discussion on the use of apomorphine subcutaneous injections in managing Parkinson’s disease.

This Week on NeurologyLive — November 15, 2021

November 15, 2021

Article

Here's what is coming soon to NeurologyLive.

RBD Shows No Impact Post-DBS, Erenumab Superior to Topiramate, ADORE Phase 3 Trial Begins

November 13, 2021

Video

Neurology News Network for the week ending November 13, 2021.

Robert Califf, MD, Nominated by Biden Administration as Next FDA Commissioner

November 12, 2021

Article

Having previously served as head of the organization during the Obama administration, Califf will replace current Acting Commissioner Janet Woodcock, MD.

NeurologyLive Friday 5 — November 12, 2021

November 12, 2021

Article

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending November 12, 2021.

The Advent of On-Demand Therapies in Parkinson Disease

November 12, 2021

Video

A brief overview of clinically available on-demand therapies used to manage morning OFF episodes in patients with Parkinson disease.

Challenges With Morning OFF Episodes in Parkinson Disease

November 12, 2021

Video

Expert neurologist Peter A. LeWitt, MD, reflects on the challenges inherent in treating morning OFF episodes in patients with Parkinson disease.

Subcutaneous ABBV-951 Infusion Superior in Parkinson Disease to Oral Formulation

November 11, 2021

Article

Those who received an infusion of ABBV-951, consisting of foslevodopa/foscarbidopa, showed statistically significant increases in hours of ON time without troublesome dyskinesia compared with oral levodopa/carbidopa.